VRA:NASDAQVera Bradley, Inc. Analysis
Data as of 2026-06-14 - not real-time
$3.79
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Vera Bradley’s stock is currently trading above its short‑term and intermediate moving averages and remains comfortably above the long‑term trend line, signaling a bullish price backdrop. The RSI sits in the upper‑mid range, suggesting momentum without imminent overbought pressure, while the MACD histogram has turned positive, confirming a bullish crossover. Volume is on the rise and market sentiment is in the “extreme greed” zone, adding further upside bias.
On the fundamentals side, the company reported its first quarter of year‑over‑year revenue growth in years, driven by improved sales and margin expansion. Although profitability remains negative, free cash flow is solid and the balance sheet shows ample cash relative to debt. Valuation metrics point to a deep discount to book value and a DCF target far above the current price, indicating significant undervaluation. However, high volatility, a beta above the market, and the consumer‑cyclical nature of the business inject notable risk into the picture.
On the fundamentals side, the company reported its first quarter of year‑over‑year revenue growth in years, driven by improved sales and margin expansion. Although profitability remains negative, free cash flow is solid and the balance sheet shows ample cash relative to debt. Valuation metrics point to a deep discount to book value and a DCF target far above the current price, indicating significant undervaluation. However, high volatility, a beta above the market, and the consumer‑cyclical nature of the business inject notable risk into the picture.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 8/10
Key Factors
- Price above key moving averages with bullish MACD signal
- Accelerating volume and strong market sentiment
- Recent quarter of revenue growth reversing a multi‑year decline
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Ongoing margin improvement but still operating at a loss
- Solid free cash flow offset by elevated debt levels
- Consumer‑cyclical exposure that could wobble with economic shifts
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Deep valuation gap to book and DCF fair value
- Potential for sustained revenue growth as brand initiatives take hold
- Undersized market cap offering upside if turnaround succeeds
Key Metrics & Analysis
Financial Health
Revenue Growth-1.70%
Profit Margin-17.74%
P/E Ratio-126.3
ROE-21.04%
ROA-6.34%
Debt/Equity53.58
P/B Ratio0.8
Op. Cash Flow$-9971000
Free Cash Flow$36.0M
Technical Analysis
TrendNeutral
RSI58.9
Support$3.00
Resistance$4.33
MA 20$3.34
MA 50$3.67
MA 200$2.80
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
Fair Value$14.94
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.16
Volatility78.09%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.